Table 2.
12 months | 24 months | 36 months | 48 months | 60 months | |
---|---|---|---|---|---|
Age 65 to <75 years (group 1) | |||||
n | 65 | 60 | 22 | 38 | 31 |
Loss ≥2 lines | 1 (1.5%) | 0 (0.0%) | 2 (9.1%) | 2 (5.3%) | 3 (9.4%) |
Age ≥75 years (group 2) | |||||
n | 109 | 95 | 42 | 46 | 32 |
Loss ≥2 lines | 2 (1.8%) | 2 (2.1%) | 0 (0.0%) | 2 (4.3%) | 3 (9.4%) |
Fellow (non-implanted) eyes | |||||
Age 65 to <75 years (group 1) | |||||
n | 65 | 60 | 22 | 38 | 31 |
Loss ≥2 lines | 4 (6.2%) | 3 (5.0%) | 2 (9.1%) | 4 (10.5%) | 5 (16.1%) |
Age ≥75 years (group 2) | |||||
n | 109 | 95 | 42 | 46 | 32 |
Loss ≥2 lines | 10 (9.2%) | 12 (12.5%) | 6 (14.3%) | 6 (13.0%) | 9 (28.1%) |